Precertification required — OMS Patient Management Unit review

All TMJ surgical precertification requests or claims are reviewed by Aetna's Oral and Maxillofacial Surgery (OMS) Patient Management Unit. Requests must include a problem-specific history (Aetna Temporomandibular Disorder Questionnaire), physical examination, TMJ radiographs/diagnostic imaging reports, records documenting 3 to 6 months of non‑surgical management (nature, results, and findings), and the proposed treatment plan; the provider will be notified of the coverage decision after review of all pertinent data.

• Include Aetna TMD Questionnaire and complete history of 3–6 months of non-surgical management
• Attach physical exam findings, TMJ radiographs/diagnostic imaging reports, and proposed surgical plan

Advanced imaging and dental radiology — coverage tied to surgical plan

Advanced TMJ imaging (e.g., 70328, 70330, 70336, 70486, 70540–70543) and certain dental/HCPCS radiology procedures (e.g., D0320–D0340) are covered only when used in conjunction with anticipated surgical management; prior authorization may be required to demonstrate that the imaging is linked to a planned surgical intervention.

• Document anticipated surgical management when submitting requests for these imaging CPTs/HCPCS
• Coverage is conditional — imaging without surgical indication is not considered medically necessary

Prior authorization expected for total TMJ replacement

Total TMJ replacement systems have specific FDA‑approved indications (arthritic conditions, ankylosis, revisions after failed prior treatments); expect prior authorization to require documentation of the indication and failed prior treatments, and supportive pre‑/post‑operative measures as part of the review.

• Provide documentation of FDA‑indicated diagnosis (e.g., osteoarthritis, ankylosis) and prior treatment failures
• Include device‑specific outcome metrics (pain scores, interincisal opening, functional status) when available

No code-level prior authorization specified in this excerpt

This excerpt does not list specific CPT/HCPCS codes or explicit prior authorization rules for the interventions discussed here; consult the full policy or coding tables for code‑level prior authorization requirements.

• Refer to the main policy coding sections for any code‑level prior authorization mandates

Prior authorization may be required for intra‑articular biologics or HA

Because randomized trials and protocols for intra‑articular biologics (PRP/PRGF) and hyaluronic acid are heterogeneous and evidence is inconsistent, prior authorization may be required; provide documentation of conservative therapy trials and the detailed treatment plan when requesting coverage.

• Document prior conservative therapy and rationale for biologic/HA use
• Include specifics of the product/protocol (preparation, dose, number of injections) in requests

Prior authorization recommended for intra‑articular and surgical TMJ procedures

For intra‑articular TMJ interventions in juvenile idiopathic arthritis (JIA) and for HA injections or arthrocentesis/arthroscopy in refractory osteoarthritis, obtain prior authorization where required and supply prior imaging and documentation of conservative management trials and clinical indications.

• Include MRI or other imaging showing TMJ inflammation/effusion for JIA cases
• Provide records of prior conservative management (NSAIDs, splinting, PT, DMARDs where applicable)

Prior authorization not specified in this section

No prior authorization rules appear in this particular section of the excerpt; the document states that some sections contain only references and policy history rather than authorization details.

• Check full policy for any plan‑specific prior authorization requirements

Prior authorization — consult main policy for code‑level rules

This section does not list specific CPT/HCPCS codes requiring prior authorization; consult the main policy document and coding tables for code‑level prior authorization requirements.

• Use the policy's coding sections to determine whether a particular code requires precertification

Conservative therapies must be exhausted before elective TMJ surgery

Surgery is considered only after exhaustion of comprehensive non‑surgical management, generally including professional physical therapy, pharmacologic therapy, behavioral therapy (CBT/relaxation), manipulation when appropriate, and reversible intra‑oral appliances for at least three months unless immediate surgery is indicated (e.g., bony ankylosis).

• Document trials and outcomes of each non‑surgical therapy in the medical record
• Immediate surgery may be justified in select cases (e.g., bony ankylosis, failed prosthesis)

Conservative‑first approach — document trials of reversible therapies

Non‑surgical conservative therapies — occlusal appliance, physical therapy, medical management, CBT, and biofeedback — should generally be exhausted and documented prior to invasive procedures; appliance trials for intracapsular problems may require wearing the appliance day and night for 2–3 months.

• For intracapsular etiologies, document appliance use through day and night (except meals) for a trial of at least 2–3 months
• Record response to physical therapy, medications, and behavioral interventions

Conservative, multidisciplinary care preferred before invasive procedures

Evidence summarized in the policy supports a conservative, multidisciplinary/palliative approach prior to additional invasive procedures; irreversible repositioning procedures are generally not supported as medically necessary for TMD.

• Prefer reversible, conservative management and document failure before considering irreversible interventions
• Irreversible mandibular repositioning procedures lack support and are not considered standard care

No formal step therapy sequencing mandated in this excerpt

The excerpt does not specify formal step therapy sequencing mandates; multiple modalities are compared in trials but no mandated order is provided in this document portion.

• Clinical judgment and documented failure of conservative options guide escalation rather than a prescriptive step sequence

Consider arthrocentesis before adjunct intra‑articular supplements

Some studies suggest arthrocentesis alone effectively reduces pain and improves jaw function; consider arthrocentesis before adding adjunctive intra‑articular supplements such as HA or PRP, and document prior arthrocentesis outcomes when requesting additional injections.

• If adjunctive supplements are proposed, include outcomes from prior arthrocentesis to justify escalation
• Provide rationale why supplements are expected to add benefit beyond arthrocentesis alone

Document failed conservative therapy before invasive interventions

Document failure or intolerance to conservative therapy (NSAIDs, splinting, physical therapy, and for JIA, DMARDs) prior to escalating to intra‑articular injections or surgery; include duration, nature of therapy, and objective findings.

• Record duration and response to NSAIDs, splint therapy, physical therapy, and any DMARDs used for JIA
• Note objective measures (pain scores, MIO) showing inadequate response prior to invasive intervention

No step therapy requirements listed here

No step therapy requirements are provided in this part of the document; the policy emphasizes documentation of prior therapies and clinical justification rather than specifying strict sequencing rules.

• Follow clinical criteria and document prior conservative care; check full policy for any plan‑specific protocols

Step therapy rules not included in this section

No step therapy rules are included in these chunks of the excerpt; refer to the complete policy for any plan‑specific step protocols.

• Consult the full policy or plan documents for specific step therapy programs

Required documentation for TMJ surgical review

Submit a problem‑specific history (Aetna TMD Questionnaire), physical examination, TMJ radiographs/diagnostic imaging reports, records documenting 3–6 months of non‑surgical management (nature, results, findings), and the proposed treatment plan when requesting surgical review; lack of these documents may lead to denial.

• Include objective measures of function and pain (e.g., MIO, VAS) and results of conservative therapy trials
• Attach imaging reports that support the surgical indication

Document surgical indication when requesting advanced TMJ imaging

Radiologic studies of the TMJ (e.g., CPTs 70328, 70330, 70336 and CT/MRI codes) are indicated and covered only when used in conjunction with anticipated surgical management; documentation should explicitly link imaging to the planned surgical intervention.

• State the anticipated surgery and how the imaging will inform the surgical plan when submitting requests
• Imaging obtained without a surgical indication may be considered not medically necessary

Suggested documentation for TMJ replacement — outcome metrics

For TMJ replacement requests, include device‑specific outcome measures and follow‑up data when available (pain scores, diet restriction, interincisal opening), and document prior conservative treatments and prior reconstructive attempts; post‑approval studies and FDA summaries cite these metrics.

• Provide pre‑ and post‑operative measures (pain VAS, interincisal opening) and prior treatment history
• Report any device‑related events or prior implant failures

Document validated outcome measures (VAS, MIO) and follow‑up

Clinical studies commonly report validated outcome measures (pain VAS, maximal mouth opening/MIO) and follow‑up time points; when submitting documentation for intra‑articular or surgical interventions, include baseline and follow‑up outcome data using these measures where available.

• Include VAS pain scores and MIO measurements at baseline and follow‑up intervals
• Specify the procedure performed, doses/volumes, and outcome time points

Include diagnosis, prior treatments, and rationale for biologic/HA use

When requesting authorization for intra‑articular biologic or viscosupplementation use, include the diagnosis (type of TMD), prior treatments and outcomes, and the clinical rationale for the proposed agent given the variable protocols and limited high‑quality evidence.

• Describe prior arthrocentesis/arthroscopy outcomes if performed
• Provide justification for selecting PRP/PRGF or HA over standard options

Essential documentation for image‑guided injections

For image‑guided TMJ injections, record patient age, diagnosis (e.g., JIA with MRI evidence of TMJ inflammation), prior conservative treatments, the specific agent injected (drug and dose), the image guidance modality used (US or CT), and objective post‑procedure outcomes (jaw pain, change in MIO, MRI effusion resolution) to support medical necessity.

• Document imaging confirmation of intra‑articular needle placement (CT or US) and any CT confirmation used
• List drug name, dose, number of injections, and expected follow‑up assessments

References/policy history — no additional documentation rules here

This portion of the document contains references and policy history and does not list additional provider documentation requirements; check the full policy for any other submission expectations.

• Refer to policy history and review dates but use the main policy text for documentation details

Policy history note — consult full policy for requirements

Policy history and review dates are provided in the excerpt; providers should refer to the full policy for comprehensive documentation and prior authorization requirements relevant to specific requests.

• Last review: 03/17/2023; Effective date recorded as 08/01/1995
• Consult the full CPB for any updates or plan‑specific instructions

Denial risk — incomplete precertification documentation for TMJ surgery

Requests for TMJ surgery lacking required documentation (Aetna TMD Questionnaire, physical exam, imaging reports, and records of 3–6 months of non‑surgical management) may be denied, because these items are specified as necessary for OMS Patient Management Unit review and coverage decisions.

• Failure to document exhaustion of non‑surgical therapies is a common reason for denial
• Ensure submitted records clearly describe the nature and results of prior conservative treatments

Denial risk — advanced imaging without documented surgical indication

Imaging CPTs listed for TMJ (70328, 70330, 70336 and related CT/MRI codes) are covered only when used in conjunction with anticipated surgical management; obtaining these studies without documenting a surgical plan may trigger denial.

• Tie imaging orders to an anticipated surgical procedure in the authorization request
• Provide imaging reports that explicitly support the surgical indication

Denial risk — contraindicated patient factors for TMJ prosthesis

Total TMJ replacement devices are contraindicated and not intended for use in patients with active or chronic infection, insufficient bone to support the device, an immature skeleton, or hyper‑functional habits (e.g., clenching/grinding); use in these scenarios may be contraindicated and could lead to denial.

• Do not submit replacement requests for patients with active infection or insufficient bone without supporting justification
• Document absence of contraindications in the medical record

No authorization/billing rules included in this portion — consult policy

This excerpt focuses on study outcomes and does not specify explicit authorization or billing requirements for certain procedures discussed; absence of code‑level authorization statements in these chunks means providers should consult the full policy or payer portal for billing rules.

• When in doubt about authorization for a specific code, contact the payer or check the full CPB coding tables

Denial risk — insufficient evidence for adjunct intra‑articular therapies

Heterogeneity and methodological inconsistencies in studies of intra‑articular HA and other adjuncts limit conclusions about efficacy; lack of high‑quality evidence may lead to coverage denial unless clear documentation of medical necessity is provided.

• Provide strong clinical justification and prior treatment documentation when requesting coverage for HA or PRP
• Acknowledge heterogeneity of protocols and include product/preparation details

Document imaging confirmation of intra‑articular needle placement

When performing image‑guided intra‑articular injections, document imaging confirmation (CT or ultrasound) of intra‑articular needle placement and the clinical indication (e.g., symptomatic TMJ arthritis, JIA) to support medical necessity and reduce risk of denial.

• Record modality used (US or CT) and any CT confirmation of intra‑articular needle tip
• Include pre‑ and post‑procedure clinical assessments (pain, MIO) in the record

References/policy history — no authorization triggers here

This references and history section contains only administrative information and does not specify authorization or denial triggers; providers should rely on the main policy text for operational requirements.

• Use the policy body for submission requirements and the references/history for provenance

Administrative information only — consult main policy for requirements

Administrative disclaimers and copyright information do not contain explicit authorization or denial triggers; refer to the policy content for clinical and billing requirements.

• Clinical requirements and coding rules are located in the main policy sections, not in the additional information block